# Effect of Sodium Glucose Co-transporter 2 Inhibitors on Left Atrial Remodeling

> **NCT05993897** · NA · UNKNOWN · sponsor: **Aswan University** · enrollment: 60 (estimated)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** Sodium Glucose Co-transporter 2 (SGLT2) Inhibitor
- **DRUG:** Rhythm control and anticoagulation

## Key facts

- **NCT ID:** NCT05993897
- **Lead sponsor:** Aswan University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-08
- **Primary completion:** 2024-08
- **Final completion:** 2024-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05993897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05993897, "Effect of Sodium Glucose Co-transporter 2 Inhibitors on Left Atrial Remodeling". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05993897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*